Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

Delayed Quote. Delayed  - 02/05 03:59:59 pm
136.05 USD   -5.11%
02/02DJILLUMINA : Posts 32% Decline in Profit
02/02 ILLUMINA : misses 4Q profit forecasts
02/02 ILLUMINA : Reports Financial Results for Fourth Quarter and Fiscal Y..
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Illumina : Combine Solicitation - TruSeq Kits

02/05/2016 | 09:54am US/Eastern

Notice Type: Combine Solicitation

Posted Date: 04-FEB-16

Office Address: Department of Health and Human Services; National Institutes of Health; National Institute of Allergy & Infectious Diseases/AMOB; 5601 Fishers Lane3rd Floor MSC 9822 Bethesda MD 20892

Subject: TruSeq Kits

Classification Code: 66 - Instruments & laboratory equipment

Solicitation Number: NOI-RML-C-1776007

Contact: Diana Rohlman, Purchasing Agent, Phone 4063639366, Email diana.rohlman@nih.gov - Lynda Kieres, Contracting Officer, Phone 406-363-9210, Fax 406-363-9288, Email lkieres@niaid.nih.gov

Setaside: N/AN/A

Place of Performance (address): National Institutes of HealthRocky Mountain Laboratories 903 S 4th St Hamilton, MT

Place of Performance (zipcode): 59840

Place of Performance Country: US

Description: Department of Health and Human Services

National Institutes of Health

National Institute of Allergy & Infectious Diseases/AMOB

This notice is a Notice of Intent. The Government intends to negotiate on a sole source basis with Illumina Inc. for the procurement of TruSeq Kits to be used with Illumina HiSeq 2500 Sequencer, cBot and MiSeq sequencer This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are not being requested and a written solicitation will not be issued. Submit offers on NOI-RML-C-1776007 This acquisition is a Notice of Intent (NOI). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 05-86-2, February 1, 2016.

The North American Industry Classification System (NAICS) code for this procurement is 325414 with a small business size standard of 500. This requirement is not set aside for small business.

The National Institute of Allergy & Infectious Diseases, Rocky Mountain Laboratories is seeking to purchase the following:

TruSeq PE Cluster Kit v3-cBot-HS CATALOG # PE-401-3001 Qty: 1 TruSeq SBS kit v3-HS-200 cycle CATALOG # FC-401-3001 Qty: 1 TruSeq(R) Stranded Total RNA LT - (with Ribo-Zero Human/Mouse/Rat) Set A CATALOG # RS-122-2201 QTY: 1

These kits are specific to the HiSeq 2500 Sequencing System. Illumina is the manufacturer of this system and compatible kits. Illumina is the sole source and does not sell through any other suppliers.

FOB Point shall be Destination; Hamilton, MT 59840.

Place of Performance: Rocky Mountain Laboratory 903 S 4th St. Hamilton, MT United States

Award will be based on the capability of the item offered to meet the above stated salient characteristics, price, past performance, delivery, warranty, and the best value to the government.

The following FAR provisions apply to this acquisition: 52.212-1 Instructions to Offerors Commercial Items (May 2014) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (May 2014)

Offerors must complete annual representations and certifications on-line at http://www.sam.gov in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items

The following contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (May 2015) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (January 2016 )

52.203-98, Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02) (FEB 2015) 52.203-99, Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02) (FEB 2015) 52.232-40 - Providing Accelerated Payments to Small Business Subcontractors. (DEC 2013)

The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://farsite.hill.af.mil/vffara.htm or, upon request, either by telephone or fax.

This is an open-market combined synopsis/solicitation/Notice of Intent for Illumina TruSeq Kits as defined herein. Illumina, Inc. as defined herein. The government intends to award a purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein.

Submission shall be received not later than February 13th 9:00 a.m. MST

Offers may be mailed, e-mailed or faxed to Diana Rohlman ; (Fax - 406-363-9288), (diana.rohlman@nih.gov). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit a capability statement, proposal or quotation that will be considered by this Agency.

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Diana Rohlman, (diana.rohlman@nih.gov)

Link/URL: https://www.fbo.gov/spg/HHS/NIH/AMOB/NOI-RML-C-1776007/listing.html

(c) 2013 Federal Information & News Dispatch, Inc., source Federal Documents

React to this article
Latest news on ILLUMINA, INC.
02/05 ILLUMINA : Combine Solicitation - TruSeq Kits
02/04 ILLUMINA : Appoints Dr. Frances Arnold to Its Board of Directors
02/03 ILLUMINA : HHS Plans Sole Source With Illumina for Maintenance of Insruments
02/03 ILLUMINA : Presolicitation Notice - Maintenance of Illumina Insruments
02/02DJILLUMINA : Posts 32% Decline in Profit
02/02 ILLUMINA : misses 4Q profit forecasts
02/02 ILLUMINA : Results of Operations and Financial Condition, Financial Statements a..
02/02 ILLUMINA : Reports Financial Results for Fourth Quarter and Fiscal Year 2015
02/02 ILLUMINA : Launches New Company
02/02 BIO RAD LABORATORIES : -Rad, Illumina Link Up for Single-Cell Genomics
News chart
Full-screen chart
Income Statement Evolution
More Financials